- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Chelsea Therapeutics International Ltd
+ Add to WatchlistCHTP:US
1.9000 USD 0.0600 3.26%As of 17:20:00 ET on 05/23/2013.
Company Profile for Chelsea Therapeutics International Ltd (CHTP)
Chelsea Therapeutics International Ltd. is a biopharmaceutical company developing a pipeline of low toxicity antifolate compounds engineered to have anti-inflammatory and anti-tumor activity. The Company's lead candidate is in development as a metabolically inert treatment alternative to Methotrexate for rheumatoid arthritis, psoriasis, and other disorders.
Contact Information
Chelsea Therapeutics International Ltd
3530 Toringdon Way
Suite 200
Charlotte, NC 28277
United States
Key Executives for Chelsea Therapeutics International Ltd (CHTP)
| Joseph G OlivetoInterim CEO | William D SchwietermanVP/Chief Medical Officer |
| L Arthur HewittVP/Chief Scientific Officer | J Nick RiehleVP:Administration/CFO |
| Michael J RobertsVP:Business Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page